PRRSV Diagnostic Peptides for Strain-Specific Antibody Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current vaccines for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) provide only partial protection against genetically heterologous strains, leading to incomplete protection against clinical symptoms and reproductive failures, and there is a need for a more detailed infectious status assessment in swine herds to differentiate between chronic and fresh infections.
Innovation Solution
A method for detecting and classifying PRRSV infections using peptides containing neutralizing epitopes from the GP3 and GP4 proteins of Type I and Type II strains, allowing for the differentiation of antigen-antibody complexes in tissue samples, and a diagnostic composition that includes these peptides for serological detection using ELISA.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current vaccines for PRRSV are used, then partial protection against genetically heterologous strains is achieved, but incomplete protection against clinical symptoms and reproductive failures occurs
Solution Approach 1:
The patent segments the diagnostic approach by using separate ELISA assays with type-specific antigens (Type I and Type II) to detect neutralizing antibodies against each strain separately. This segmentation allows precise identification of which strain the animal is protected against, enabling tailored vaccination strategies that address the limitation of partial cross-protection.
Solution Approach 2:
The patent changes the diagnostic parameter from general PRRSV detection to specific neutralizing antibody detection against Type I or Type II strains. By measuring neutralizing antibody titers against each strain separately, the system provides detailed information about strain-specific protection, allowing veterinarians to adjust vaccination strategies based on the actual immune status rather than applying blanket vaccination protocols.
2Measurement precision
If general PRRSV detection methods are used, then infection presence is identified, but differentiation between chronic and fresh infections is not achieved
Solution Approach 1:
The patent segments the infection detection into multiple time-point measurements. By conducting ELISA assays at different time points and comparing neutralizing antibody titers, the system can distinguish between chronic infections (consistently positive over time) and fresh infections (recently converted from negative to positive). This temporal segmentation recovers the infection timeline information that would otherwise be lost.
Solution Approach 2:
The patent implements a feedback mechanism by comparing neutralizing antibody titer results across multiple time points. The system uses the change in antibody levels over time as feedback to classify infection status: rising titers indicate fresh infections, while stable or declining titers suggest chronic infections. This feedback loop restores the ability to differentiate infection timelines.
3Measurement precision
If type-specific antigen detection is implemented, then precise differentiation between Type I and Type II infections is achieved, but diagnostic complexity increases
Solution Approach 1:
The patent segments the diagnostic system into separate, standardized ELISA assays for Type I and Type II detection. Each assay uses a specific antigen and detects neutralizing antibodies against that strain. This segmentation maintains measurement precision while managing complexity through modularity - each assay can be performed independently using standard laboratory equipment, avoiding the need for complex single-platform systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables a more precise evaluation of infection status in swine herds, allowing for tailored vaccination strategies and improved management of PRRSV, with high specificity and sensitivity in distinguishing between Type I and Type II infections, even in cases of chronic or repeated infections.
Implementation Method 1
incubation of tissue samples taken from the animals with at least one antigen capable to bind a neutralizing antibody against the Type I-virus possibly present in the animal and with at least one antigen capable to bind a neutralizing antibody against the Type II-virus possibly present in the animal
Data Source
AI summary
Method for the detection and classification of PRRSV-infections in swine herds, comprising a) the incubation of tissue samples taken from the animals with at least one antigen capable to bind a neutralizing antibody against the Type I-virus possibly present in the animal and with at least one antigen capable to bind a neutralizing antibody against the Type II-virus possibly present in the animal, b) testing whether a binding of antibodies against the Type I-virus and/or the Type II-virus has taken place and c) determining from the presence of possible epitope-antibody complexes whether an infection of the PRRSV I-Type and/or PRRSV II-Type is present in the herd and diagnostic compositions for such a method.